Blue Sky, Partners Group Acquire Majority Stake in HPS
July 13, 2015
Blue Sky Private Equity, with participation from Partners Group, has acquired a majority stake in HPS. Founded in 1975 and generating annual revenues in excess of $130 million, HPS is an outsourced hospital and oncology pharmacy service business in Australia. The company is currently running trials for the production of compounded chemotherapy drugs in two facilities awaiting Therapeutic Goods Administration approval.